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Plasmodium falciparum encoded histidine rich protein (HRP2) based malaria rapid diagnos-
tic tests (RDTs) are used in India. Deletion of pfhrp2 and pfhrp3 genes contributes to false
negative test results, and large numbers of such deletions have been reported from South
America, highlighting the importance of surveillance to detect such deletions.
Methods
This is the first prospective field study carried out at 16 sites located in eight endemic states of
India to assess the performance of PfHRP2 based RDT kits used in the national malaria con-
trol programme. In this study, microscopically confirmed P. falciparum but RDT negative sam-
ples were assessed for presence of pfhrp2, pfhrp3, and their flanking genes using PCR.
Results
Among 1521 microscopically positive P. falciparum samples screened, 50 were negative by
HRP2 based RDT test. Molecular testing was carried out using these 50 RDT negative sam-
ples by assuming that 1471 RDT positive samples carried pfhrp2 gene. It was found that
2.4% (36/1521) and 1.8% (27/1521) of samples were negative for pfhrp2 and pfhrp3 genes,
respectively. However, the frequency of pfhrp2 deletions varied between the sites ranging
from 0–25% (2.4, 95% CI; 1.6–3.3). The frequency of both pfhrp2 and pfhrp3 gene deletion
varied from 0–8% (1.6, 95% CI; 1.0–2.4).
Conclusion
This study provides evidence for low level presence of pfhrp2 and pfhrp3 deleted P. falcipa-
rum parasites in different endemic regions of India, and periodic surveillance is warranted
for reliable use of PfHRP2 based RDTs.
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Introduction
Malaria is a major public health problem in India, which has the highest number of malaria
cases outside of Africa. Malaria prevalence in India varies between states and eight out of 35
states and union territories are contributing to 80% of total malaria cases, 85% Plasmodium fal-
ciparum, and 70% of deaths due to malaria in the country [1]. P. falciparum infection can
become a life threatening disease, if not diagnosed early and treated [2].The introduction of
malaria Rapid Diagnostic Tests (RDTs) has made it possible to obtain diagnostic results
quickly and provide treatment in a timely manner. The availability of RDTs and the scale of
their use in India have rapidly increased in recent years [3] along with the global increase in
their use from 46 million in 2008 to 319 million in 2013 [4]. Most of the commercially available
RDTs detect histidine-rich protein 2 (HRP2) which is produced during the asexual blood stage
of P. falciparum but not by other species of malaria parasites making PfHRP2 based RDT spe-
cies specific [5]. Some PfHRP2 based RDTs can cross react with HRP3 encoded by pfhrp3 gene
due to shared antigenic epitopes between these proteins [6]. Pfhrp2 and pfhrp3 are structural
homologue and their respective genes are located on chromosome 8 and chromosome 13 [7].
The plasma level of PfHRP2 has been shown to be a surrogate marker for the severity of P. fal-
ciparummalaria in some studies [8] as it can indirectly reflect the parasite load of sequestered
parasites [9]. It may also be used as marker to differentiate between uncomplicated and severe
malaria [10].
We have evaluated various brands of RDTs in various epidemiological settings in India with
differing results in the past [11, 12]. The sensitivity of various RDTs ranged from 76% to 98%
[3]. One major concern with RDT performance is the presence of false negative results which
can lead to misdiagnosis and failure to treat. Several factors can contribute to false negative test
results such as low parasite densities [3], incorrect interpretation of RDT results, prozone effect
[13], or pfhrp2 gene deletion [14]. The first evidence for large scale pfhrp2 and pfhrp3 gene
deletion came from Peru [15] and was further substantiated by other researchers [7, 14, 16, 17].
Such a large scale deletion of pfhrp2 has been found only in different parts of South America.
Studies conducted in Africa and Asia showed pfhrp2 deletion in a small number of parasite iso-
lates [18–21]. We do not know if the false negative result in various RDT evaluation studies we
conducted were at least partially due to pfhrp2 negative strains. There is very limited informa-
tion about the extent of pfhrp2 and pfhrp3 gene deletion in P. falciparum parasites in South
Asia. A small previous study conducted in Chhattisgarh state, India, revealed two out of 48
samples showed pfhrp2 deletion [18]. It is important to monitor pfhrp2 negative parasites pres-
ent in P. falciparum populations, because in India, RDTs are used in the national malaria pro-
gramme to diagnose malaria for case management in regions where microscopic diagnosis is
not available. Therefore, the main objective of this study was to determine whether there is fur-
ther evidence to confirm the presence of pfhrp2 and pfhrp3 deleted P. falciparum parasites in
eight highly endemic states in India.
Material and Methods
We conducted a prospective study to determine the prevalence of pfhrp2 and pfhrp3 gene dele-
tion in P. falciparum positive samples confirmed by microscopy. Samples were collected from
16 sites in eight malaria endemic states in India (Fig 1); two sites were selected from each state
one having high malaria endemicity (Annual Parasite Incident> 5) and other one having low
malaria endemicity (Annual Parasite Incident<2).
Positive P. falciparum samples were collected from July to December 2014 simultaneously
from all sites during the rainy season and coinciding with the main transmission season [22].
These States are Odisha (OD), Chhattisgarh (CG), Jharkhand (JH), Madhya Pradesh (MP),
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Maharashtra (MH), Rajasthan (RJ), Gujarat (GJ), and Tripura (TR). Two community health
centres (CHCs) representing a high endemic and low endemic regions were chosen from each
State. During the study, we screened all febrile patients who attended the CHC hospital
Fig 1. Map showing the study sites from eight malaria endemic states of India. Each state has two study sites.
doi:10.1371/journal.pone.0157949.g001
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requiring malaria diagnosis. The patients were enrolled under the study after obtaining written
informed consent from patients or their guardians. The blood smears were stained with JSB
[23] and examined under the microscope. Those found positive were treated as per existing
National Vector Borne Disease Control Programme (NVBDCP) policy [22]. The inclusion cri-
teria for sample collection included positive identification of P. falciparummono-infection by
microscopy in the blood smears of symptomatic patients over the age of 5 year. Pregnant
women were excluded from the study. 1-2ml venous blood samples were collected in heparin
coated vacutainer and after plasma separation samples were stored under freezing conditions
for further molecular studies. The blood smears were examined independently by two micros-
copists and if there was a discrepancy in the result, a third expert microscopist read the slide
and confirmed the results. Parasite densities were calculated according to the standard tech-
nique (Parasites/μL = no. of asexual parasites X 8000/no. of WBC counted).
To test our working hypothesis that low level of pfhrp2 deleted parasites may be widely pres-
ent in different endemic states of India, we carried out the following sample size calculation. In
a previous study conducted in the Chhattisgarh State of India 4% pfhrp2 gene deletion was
reported [18]. Therefore, to estimate the prevalence of P. falciparum infected individuals carry-
ing pfhrp2 deleted parasites with 95% level of confidence and 25% relative precision, assuming
a 4% pfhrp2 gene deletion rate, an overall sample size of 1536 P. falciparum cases were
required.
The prevalence of pfhrp2, pfhrp3, and flanking gene deletion was determined by dividing
the number of isolates by the total number of enrolled P. falciparum subjects. The study was
approved by ethics committee of National Institute for Research in Tribal Health (ICMR).
Written informed consent was signed by participants and their parents/guardians if they were
minors.
Rapid diagnostic test
Bivalent malaria RDT was performed immediately from collected blood samples as per manufac-
turer’s protocol by taking 5 μL of whole blood with the help of circular loop provided by the man-
ufacturer {SD Bioline Malaria Antigen P.f./P.v. (05FK80I-40), Bio Standard Diagnostics Pvt. Ltd.,
India}. The results were interpreted within the specified reading time of the manufacture’s proto-
col (15–30 minutes). RDT was also repeated for samples which gave negative results.
DNA extraction
Genomic DNA was extracted from 200 μL of whole blood using QIAamp DNA blood mini Kit
(Qiagen, Germany) as per the manufacturer’s protocol and stored at –20°C for further molecu-
lar biology studies.
Species specific PCR. Presence of P. falciparum infection in all the samples was further
confirmed by PCR using 18S ribosomal RNA (rRNA) gene amplification. Species specific
nested PCR was performed [24] and detailed protocol was described earlier [25]. To check the
quality of isolated genomic DNA, PCR amplification of two more genes, P. falciparummerozo-
ite surface protein 1 (pfmsp1), and P. falciparummerozoite surface protein 2 (pfmsp2), was per-
formed using specific primers [26]. In brief, for primary PCR 5μL of genomic DNA was taken
as template and for nested PCR 2μL of 1:10 diluted primary PCR product was taken as tem-
plate. Primer sequences and PCR cycling conditions were used as given in Table 1. PCR reac-
tion was performed in a 25μL reaction mixture containing 10X buffer, 1mMMgCl2, 0.2mM
each dNTP, 0.4μM each primer, and 0.2 units of Taq polymerase (Invitrogen, life technologies)
with initial denaturation at 95°C for 5 min, and final extension at 72°C for 8 min. All the PCR
products were analyzed in 1.2% agarose gel and image was captured under GelDoc-It2 imager.
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Detection of pfhrp2 and pfhrp3 genes. Samples showing amplification for all three genes
(18S rRNA,msp1,msp2) were sequenced in the study. Samples which were microscopically
and PCR positive for P. falciparum and negative by RDT were subjected to pfhrp2, pfhrp3, and
flanking genes of pfhrp2 and pfhrp3 PCR amplification. PCR amplification of DNA fragments
encompassing exon1, intron, exon2, and fragment encompassing exon2 of pfhrp2 and pfhrp3
genes was performed using specific primers for confirmation of deletion of these genes using
previously described method [7, 27]. Primers and PCR cycling conditions used for amplifica-
tion of these genes are given in Table 1.
Detection of genes flanking pfhrp2 and pfhrp3 by PCR. PCR was also performed for
flanking genes, pfhrp2 upstream (PF3D7_0831900), pfhrp2 downstream (PF3D7_0831700),
and pfhrp3 upstream (PF3D7_1372100), pfhrp3 downstream (PF3D7_1372400) using specific
primers for confirmation of deletion of these genes [7]. PCR cycling conditions used for ampli-
fication of these genes are given in Table 1. The composition of reaction mixture was the same
as for amplification of pfhrp2 and pfhrp3 genes. Parasite strains of P. falciparum 3D7 and Dd2
were taken as positive and negative controls, respectively, for pfhrp2 because 3D7 is known to
have all pfhrp2, pfhrp3, and flanking genes while Dd2 is lacking pfhrp2and its flanking genes
[28]. Another P. falciparum strain, HB3 isolated from Honduras, was used as a negative control
of pfhrp3 and its flanking genes because of absence of all these genes [29]. These controls were
obtained fromMalaria Branch at CDC, Atlanta USA.
All PCR products were separated and visualized on a 2% agarose gel. When there was a pos-
itive reaction, results was accepted without further repetition. When a negative test result was
obtained, the amplification was repeated for confirmation. If the second result was concordant
with the first, this was accepted as the final result. However, if the second result was discordant
with the previous test result, the experiment was conducted for a third time. The two matching
result out of these three were scored as the final result.
DNA sequencing of pfhrp2 and pfhrp3 gene. All the positive amplification of pfhrp2 and
pfhrp3 genes (exon2) were sequenced from both directions by using forward and reverse prim-
ers of exon2. PCR products were purified by using spin columns (Real Biotech Corporation,
Taiwan) according to manufacturer’s instructions and were used in a standard dye terminator
(BigDye Terminator v3.1 Cycle Sequencing Kit) DNA sequencing on an Applied Biosystems
3130 XL sequencer.
Sequencing result analysis and translation. Sequencing results were analysed by using
sequencing analysis software v5.2 (Applied Biosystems) and were assembled using CAP contig
assembly programme of BioEdit sequence alignment editor. Nucleotide sequences were trans-
lated to amino acid sequences using ExPASy translate tool. Amino acid repeat sequences were
identified and given numeric codes [27]. Nucleotide and amino acid sequences were submitted
to the NCBI database.
Results
From the 16 study sites, a total of 22765 suspected malaria patients were screened for malaria
by microscopy of which 2693 were positive for malaria (11.8%). Out of 2693 malaria subjects,
1999 were P. falciparum (74%), 645 P. vivax (24%), and 49 had mixed infections of P. falcipa-
rum and P. vivax (2%) as shown in Fig 2.
RDT Performance
Out of 1999 P. falciparummono-infections, 1521 subjects were enrolled in the study and the
rest either left the hospital before enrollment or refused to give consent for enrollment. Bivalent
malaria RDT kit was performed among the enrolled patients and overall 3.3% (50/1521) of P.
Prevalence of pfhrp2 and pfhrp3Deletion in India
PLOS ONE | DOI:10.1371/journal.pone.0157949 August 12, 2016 6 / 16
falciparum confirmed cases were found to be RDT negative (Table 2). Therefore, these 50 RDT
negative samples were chosen for further molecular testing to detect if there is lack of pfhrp2,
pfhrp3 or their flanking genes. The rest of 1471 specimens were assumed to be carrying a func-
tional pfhrp2 gene as these specimens showed positive RDT results. The majority of RDT nega-
tive cases (2.6%) were from three states (40/1521), i.e. GJ, 11.3% (11/97), OD, 7.1% (19/267),
and JH, 4.6% (10/216). The remaining 10 samples were from CG 1.4% (3/214), MH 1.7% (4/
234), MP 0.9% (2/226), and TR 0.8% (1/127) while samples from RJ (n = 140) showed 100%
matching results between RDT and the microscopy.
Fig 2. Flow chart showing Screening of malaria cases by microscopy, RDT and polymerase chain reaction (PCR) for pfhrp2 and pfhrp3 gene.
doi:10.1371/journal.pone.0157949.g002
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A nested PCR reaction that amplifies the 18S rRNA gene of five Plasmodium species (P. fal-
ciparum, P.vivax, P.malariae, P. ovale, and P. knowlesi) infecting humans and two polymor-
phic P. falciparum genes pfmsp1 and pfmsp2 was undertaken for confirmation of malaria
Table 2. Details of patients screening, positive, enrolled and RDT negative.
State CHC (Longitude, latitude and
mean sea level)










Orissa Bandhugaon, District Koraput 758 349 311 229 18 (7.86) (4.7–
12.1)
12 (5.2) 12 (5.2) 11 (4.8)
(82.72°E,18.82°N, 870 m)
Jagannathpur,District Rayagada 280 40 38 38 1 (2.63) (0.1–
13.8)
0 (0.0) 0 (0.0) 0 (0.0)
(83.42°E, 19.17°N, 207 m)
Jharkhand Jaldega,District Simdega 949 191 146 118 4 (3.39) (0.9–
8.5)
3 (2.5) 2 (1.7) 2 (1.7)
(84.52°E, 22.62°N, 418m)
Bano,District Simdega 2275 272 132 98 6 (6.12) (2.3–
12.9)
2 (2.0) 1 (1.0) 0 (0.0)
(84.92°E, 22.62°N, 418 m)
Chhattisgarh Jagdalpur 4336 386 355 202 0 (0.00) (0.0–
1.8)*
0 (0.0) 0 (0.0) 0 (0.0)
(82.03°E, 19.07°N, 552 m)
Baikunthpur 3116 23 16 12 3 (25.00) (5.5–
57.2)
3 (25.0) 0 (0.0) 0 (0.0)
(82.55°E, 23.25°N, 556 m)
Madhya
Pradesh
Ranapur,District Jhabua 1503 310 153 125 0 (0.00) (0.0–
2.9) *
0 (0.0) 0 (0.0) 0 (0.0)
(74.6°E 22.77°N 318 m)
Pushprajgarh,District Anuppur 1648 163 142 101 2 (1.98) (0.2–
7.0)
2 (2.0) 2 (2.0) 2 (2.0)
(81.68°E, 23.1°N,505 m)
Maharshtra Malewada,District Gadchiroli 1163 121 116 114 3 (2.63) (0.5–
7.5)
3 (2.6) 3 (2.6) 3 (2.6)
(80.0°E, 20.10°N, 217 m)
Darekasa,District Gondia 1113 135 126 120 1 (0.83) (0.0–
4.6)
0 (0.0) 0 (0.0) 0 (0.0)
(80.19°E, 21.46°N, 300m)
Rajasthan Barabarda,District Pratapgarh 434 5 0 0 0 (0.00) 0 (0.0) 0 (0.0) 0 (0.0)
(74.8°E, 24.3°N, 580 m)
Bekaria,District Udaipur 678 215 158 140 0 (0.00) (0.0–
2.6)*
0 (0.0) 0 (0.0) 0 (0.0)
(73.68°E, 24.58°N, 600 m)
Gujarat Devgadh Baria,District Dahod 2755 318 169 87 11 (12.64) (6.5–
21.5)
10 (11.5) 7 (8.0) 7 (8.0)
(74°150E, 22°520N, 280 m)
Lavkar,District Valsad 461 15 10 10 0 (0.00) (0.0–
30.8)*
0 (0.0) 0 (0.0) 0 (0.0)
(72.93°E, 20.61°N, 13 m)
Tripura Manu bazar,South Tripura 168 51 45 45 0 (0.00) (0.0–
7.9)*
0 (0.0) 0 (0.0) 0 (0.0)
(91°290E, 23°320N, 26 m)
Santir bazar,South Tripura 1128 99 82 82 1 (1.22) (0.0–
6.6)
1 (1.2) 0 (0.0) 0 (0.0)
(91°290E, 23°320N, 26 m)
Total 22765 2693 1999 1521 50 (3.29) (2.4–
4.3)
36 (2.4) 27 (1.8) 25 (1.6)
*One-sided, 97.5% confidence interval; Pos: Positive for Malaria; Pf: Plasmodium falciparum
doi:10.1371/journal.pone.0157949.t002
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parasite species, and quantity and quality of P. falciparum parasites DNA (Fig 3). Results of
these experiments confirmed that all 50 samples were positive for P. falciparum (18SrRNA,
pfmsp1 and pfmsp2 genes), with no evidence of contamination, or co-infection with another
Fig 3. Molecular analysis of RDT negative P. falciparum samples.Nested PCR amplification of genes; Upstream (MAL7P1.230)
and downstream (MAL7P1.228) flanking genes of pfhrp2, pfhrp2 exon 1–2 (hrp2-12), pfhrp2 exon2 (hrp2-2), upstream (MAL13P1.475)
and downstream (MAL13P1.485) flanking genes of pfhrp3, pfhrp3 exon 1–2 (hrp3-12), pfhrp3 exon2 (hrp3-2). Each gel picture shows
100bp marker on 1st well then amplified gene of samples with their positive and negative controls respectively.
doi:10.1371/journal.pone.0157949.g003
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parasite species S1 Table. Population marker genes (pfmsp1 & pfmsp2) showed 18% (9/50)
multiple allelic types among the RDT negative samples. Of these 9 cases, 6 were positive for
pfhrp2 while only 3 cases were negative for pfhrp2. The peripheral parasite density was calcu-
lated from 1338 cases (46 from RDT negative and 1292 from RDT positive). Out of 46 RDT
negative cases 22% (10/46) had parasite density<200/microliter, 30% (14/46) had parasite
density between>200–500 /microliter and 48% (22/46) had parasite density>500/microliter.
Three of these subjects had very high parasitemia (>5000 parasite/μL,>10,000 parasite/μL,
and>20,000 parasite/μL).
pfhrp2, pfhrp3 and its flanking gene deletions
PCR amplification showed 2.4% samples (36/1521) were lacking the pfhrp2 gene. Most cases
(1.8%) (27/1521) were from the three states i.e. GJ 10.3% (10/97), OD 4.5% (12/267) and JH
2.2% (5/216) (Table 2). The remaining nine samples were from CG 1.4% (3/214), MH 1.3%
(3/234), MP 0.9% (2/226), and TR 0.8% (1/127). Only 27 samples showed absence of the
pfhrp3 gene (1.7%) and both pfhrp2 and pfhrp3 genes were not found in 1.6% (25/1521) sam-
ples by PCR.
Gene deletion patterns of pfhrp2 and pfhrp3 genes
Nineteen different types of pfhrp2 and pfhrp3 gene deletion patterns were observed
(Table 3). Out of 50 isolates, only seven isolate (14%) had all the pfhrp2 and pfhrp3, and their
flanking genes, while 86% isolates had deletion of either pfhrp2 or pfhrp3, or their flanking
genes. Further analysis revealed that 14% of isolates lacked all the genes including their flank-
ing genes. Another 14% isolates showed complete lack of pfhrp2 and its flanking genes while
positive for pfhrp3 and its flanking genes.
Variation in pfhrp2 and pfhrp3 genes. Exon2 of all 16 positive samples for pfhrp2 and 23
positive samples for pfhrp3 were sequenced. A total of 14 different amino acid repeats were
identified from pfhrp2 gene and 8 different amino acid repeat from pfhrp3 gene (Table 4). Type
1 (AHHAHHVAD), type 2 (AHHAHHAAD), type 7 (AHHAAD), and type 12 (AHHAAAHHEAATH)
repeats were observed in 100% of the isolates. Several other repeats occurred only in a few iso-
lates. The sequences were submitted to the Gen Bank database (Gen Bank accession numbers
KT 238913-KT 238939).
Discussion
This is first systematic study from India to document the prevalence of the pfhrp2 and pfhrp3
genes in natural P. falciparum populations in eight endemic states responsible for 80% of total
malaria cases, 85% Plasmodium falciparum, and 70% death due to malaria in the country [1].
The study design involved identification of false RDT negative samples by microscopy and
PCR amplification of pfhrp2 and pfhrp3 genes along with their upstream and downstream
flanking genes in order to estimate the extent of deletion around pfhrp2 and pfhrp3. Recent
studies of pfhrp2 gene deletion in natural P. falciparum population from Peru and other coun-
tries [14, 17, 19] have demonstrated the importance of molecular surveillance to detect these
deletions as they could lead to false negative diagnoses when pfhrp2 based RDTs are used. We
performed several sets of PCR experiments to confirm that P. falciparum specimens actually
lack these genes. These experiments also ensured that the negative PCR reaction for pfhrp2 and
pfhrp3 were not due to poor quality or insufficient parasite DNA.
Prior to this study, we did not know whether P. falciparum parasites with pfhrp2 deletion
were found in the highly endemic states of GJ, OD, and JH. The results of this study confirm
that pfhrp2 deletions occur in natural P. falciparum parasite populations in India in varying
proportions in different highly endemic CHCs (0–25%) and states (0–11%). These results
Prevalence of pfhrp2 and pfhrp3Deletion in India
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suggest that spontaneous pfhrp2 deletions occur under natural field conditions with intense
transmission as recorded earlier [14, 17, 19]. Moreover, simultaneous infection with different
P. falciparum parasites (multiple genotypes) is also recorded in 18% RDT negative samples.
Thus the 36 pfhrp2 negative out of 50 RDT negative and blood smear positive specimens does
not provide the correct estimate of the pfhrp2 negative frequency of P. falciparum. This is
because one pfhrp2 positive parasite in a specimen with another pfhrp2 negative strain may
produce a pfhrp2 positive test results [19].Thus the actual prevalence of pfhrp2 negative strains
could be higher than the estimate reported in this study. In addition, we assumed all 1471 spec-
imens from RDT and microscopy positive individuals were positive for pfhrp2 and pfhrp3
genes and therefore not included in the molecular analysis. Given that HRP2 and HRP3 pro-
teins share common epitopes, it is possible that we may have under estimated prevalence of
especially pfhrp3 genes since positive HRP2 RDT test result need not necessarily reveal whether
pfhrp3 is present or not. However, the main goal of this study is to estimate the prevalence of
pfhrp2 gene, which codes for HRP2 proteins captured by P. falciparum specific RDTs.
Although overall results suggested that the majority of persons with P. falciparum infections
are positive using PfHRP2 based RDTs>97% and that PfHRP2 based RDTs are useful for
diagnosis especially in regions where skilled microscopists are not available. However, it is of
concern that false negative PfHRP2 based RDTs were obtained in some CHCs i.e. Bandhugaon
in OD, Devgadh Baria in GJ, and Baikunthpur in CG and thus a negative test results with an
RDT based on PfHRP2 (SD Biolines used in this study) does not exclude active infection with
Table 4. Amino acids repeats alongwith codes observed in Plasmodium falciparum histidine rich pro-
tein 2 and 3.
Code Repeat sequences Antigens observed
HRP2 HRP3
1 AHHAHHVAD + +
2 AHHAHHAAD + -
3 AHHAHHAAY + -
4 AHH + +
5 AHHAHHASD + -
6 AHHATD + -
7 AHHAAD + +
8 AHHAAY + -
9 AAY + -
10 AHHAAAHHATD + -
11 AHN - -
12 AHHAAAHHEAATH + -
13 AHHASD + -
14 AHHAHHATD - -
15 AHHAHHAAN + +
16 AHHAAN - +
17 AHHDG - +
18 AHHDD - +
19 AHHAA + -
20 SHHDD - +
21 AHHAHHATY - -
22 AHHAHHAGD - -
23 ARHAAD - -
24 AHHTHHAAD - -
doi:10.1371/journal.pone.0157949.t004
Prevalence of pfhrp2 and pfhrp3Deletion in India
PLOS ONE | DOI:10.1371/journal.pone.0157949 August 12, 2016 12 / 16
P. falciparum. Moreover, all these 3 CHC's are located in high endemic regions. Multiple infec-
tion (MOI) with P. falciparum strains was limited to 18% and these cases were mainly found in
4 states i.e. OD, JH, GJ and MH.
All samples lacking pfhrp2 were found in symptomatic patients and occurred at both high
and low parasitemia as reported in Peru [16]. This is in contrast to an earlier finding which
showed pfhrp2 gene deletions only in asymptomatic subjects with low parasitemia [19]. It has
also been demonstrated that PfHRP3 is likely to compensate for absence of PfHRP2 in diagno-
sis due to cross-reaction of PfHRP2 with PfHRP3 antibodies [15, 20, 27]. However, in this
study 25 subjects, out of 50 lacked both pfhrp2 and pfhrp3 genes. Moreover, the role of pfhrp3
in performance of HRP based diagnostic tests is not well defined [15].
Although among 50 RDT negative samples tested we found higher levels of pfhrp2 deletion
than pfhrp3, we cannot generalize this for the whole country without further studies. However,
it is worth pointing out that in some countries such as Suriname pfhrp2 deletion was more
common than pfhrp3 [17]. In contrast, in some countries viz Colombia [14], Peru [15], and
Honduras [7] pfhrp3 deletions are more prevalent than pfhrp2 deletion.
Three major factors can affect the sensitivity of the PfHRP2 based RDT i.e. parasite density,
pfhrp2 polymorphisms, and pfhrp2 deletion. The parasite density cannot explain the failure of
the detection by PfHRP2 based RDT as there were 48% subjects with high parasitemia showed
RDT negative test results for P. falciparum (>500 parasite/μL). Another factor affecting the
sensitivity of the PfHRP2 based RDT is failure of parasite to express the antigen or alteration in
PfHRP2 protein sequence due to gene deletion, insertion, pattern of histidine repeats, and
SNPs [20, 21, 30]. There were some isolates that were PCR positive for pfhrp2 gene (14/50) but
showed false negative RDT test results. Although we do not know the reason for this false nega-
tive test result, it is possible that variation in composition of pfhrp2 sequence repeat as well as
the number of repeat types could have influenced the test results. The amino acid composition
of the PfHRP2 protein (organization of the repeats and position of repeats in the antigens) may
have an impact on RDT sensitivity [27, 30]. Multiple patterns of deletion (Table 3) within the
region of pfhrp2, pfhrp3, and its flanking genes was present in this study and these kinds of pat-
terns have been reported previously [14]. This kind of multiple gene deletion patterns could be
due to their physical location on the chromosomes [7].
The results suggest that the pfhrp2 and pfhrp3 deletion phenomenon is also found in India
in varying proportions but at a lower proportion. This finding is valuable for laboratories and
health policy makers as it showed that PfHRP2 based RDTs can be reliably used in most parts
of India where this study was performed. However, even though the prevalence of pfhrp2/
pfhrp3 negative parasites are low in most part of the country, the frequent migration or selec-
tion of pfhrp2 parasites could lead to their spread to other parts of the country as was the case
for drug resistance parasites. Moreover, the patients with negative PfHRP2 based RDTs will
not be treated for malaria and this could lead to selection of pfhrp2 negative parasites as
NVBDCP policy is to use RDTs for malaria diagnosis and treatment in areas where it is not
possible to provide results of microscopy within 24 hrs. If the parasites are undetected by these
RDTs, the delay in treatment supports the development of sexual stages and their transmission
to mosquitoes during a blood meal. The transmission of parasites undetected by PfHRP2 based
RDT would continue, leading to faster selection and dissemination of these genotypes [20].
The frequency of these genotypes would then increase in coming years from these areas like GJ
(Devgadh Baria CHC, district Dahod), OD (Bandhugaon CHC, district Koraput), CG (District
hospital, district Korea). These districts are also known as highly malarious ones in their
respective states.
The strength of this study is that samples were collected from 16 sites in eight endemic states
simultaneously during the main transmission season from different geographical regions of the
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country to understand the pattern of hrp2 and hrp3 gene deletions in the areas of different
endemicity. Nevertheless, this study has some limitations. The samples were collected only
during one season, thus the pattern of the distribution of pfhrp2 and pfhrp3 deletions are not
known during other seasons of the year. Moreover the prevalence of pfhrp3 gene deletions esti-
mated in this study may be an underestimate as RDT positive samples were not tested for
pfhrp3 deletion. Another limitation of the study is the number of samples examined from the
highly malarious state of Tripura as transmission start much earlier in May as compared to
other states where main transmission season starts from July onwards with the onset of rains.
A larger and more systematic collection in large parts of Gujarat, Odisha, Jharkhand, and
Chhattisgarh will clarify the current prevalence and distribution of P. falciparum strains with
pfhrp2 and pfhrp3 deletions in these states. Periodic evaluation of RDT performance and
molecular surveillance will be required to ensure the reliable performance of RDTs and to
monitor changes in the level of pfhrp2 deleted parasites in different parts of India.
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